Lung nodules are extremely common, and the vast majority are harmless. According to U.S. data, more than 95% of all pulmonary nodules found on CT scans turn out to be benign.1PubMed Central. Incidental Pulmonary Nodules: Differential Diagnosis and Clinical Management They show up on chest imaging so frequently that radiologists have detailed guidelines for deciding which ones deserve a second look and which can be safely ignored. Still, the word “nodule” on a radiology report can be alarming, and understanding what drives the small percentage that do turn out to be cancer is worth knowing.
Why Lung Nodules Are Found So Often
A lung nodule is a small spot on the lung, typically less than three centimeters across. Modern CT scanners are sensitive enough to pick up spots just a few millimeters in size, and at that resolution, all kinds of minor tissue changes become visible. Old infections, tiny lymph nodes, small areas of scarring, and benign growths called hamartomas all show up as nodules. In areas of the United States where certain fungal infections are widespread, healed granulomas from past exposures to organisms like histoplasma or coccidioides are an especially common source.2CHEST Pulmonary. Endemic Mycoses for Pulmonary Clinicians: From Nodules to ARDS Many people have had mild fungal lung infections without ever knowing it, and the small calcified spot left behind is essentially a scar with no ongoing significance.
Calcified nodules in particular tend to have a short list of possible causes. These include calcified granulomas, hamartomas, and occasionally metastases from bone or cartilage cancers, though the first two are by far the most frequent.3PubMed Central. The calcified lung nodule: What does it mean? When a radiologist sees a densely calcified, smoothly bordered nodule, it almost always means the nodule is benign, and further workup is rarely needed.
How Often Nodules Turn Out to Be Cancer
Among people whose CT scans reveal nodules, the cancer rate is in the low single digits. In two large screening datasets, the rate of cancer among people who had at least one nodule was about 4% to 5.5%.4PubMed Central. Probability of cancer in pulmonary nodules detected on first screening CT That means for every 100 people walking around with a nodule on their scan, roughly 95 or more have something completely benign. The challenge, of course, is figuring out which few deserve closer attention.
The number of nodules a person has does not dramatically change the odds. In the Dutch-Belgian NELSON screening study, cancer probability was about 3.6% in people with a single nodule and rose only modestly with more nodules, reaching about 6.3% in people with four. Interestingly, people with more than four nodules actually had a slightly lower cancer rate of about 3.3%, which likely reflects the fact that having many tiny nodules often signals a diffuse benign process rather than a malignancy.5PubMed Central. Lung cancer screening by nodule volume in Lung-RADS v1.1: negative baseline CT yields potential for increased screening interval
What Makes a Nodule Look Suspicious
Radiologists assess several features to gauge whether a nodule is likely benign or warrants further investigation. Size matters most: a nodule under six millimeters is far less likely to be cancerous than one over a centimeter. But size alone does not tell the whole story.
The edges of the nodule are revealing. A smooth, well-defined border is reassuring. A spiculated margin, meaning the edges look like they have tiny spikes radiating outward, is one of the strongest visual indicators of malignancy.6PubMed Central. Spiculation Sign Recognition in a Pulmonary Nodule Based on Spiking Neural P Systems Lobulated contours and distortion of the blood vessels running near the nodule also raise concern.7PubMed. Solitary pulmonary nodules: Part I. Morphologic evaluation for differentiation of benign and malignant lesions A round, smooth nodule sitting quietly in the lung parenchyma is a very different story from an irregularly shaped one pulling on surrounding tissue.
Location and growth over time add more context. Nodules in the upper lobes carry somewhat higher risk, and any nodule that grows between two scans taken months apart gets escalated quickly. This is why follow-up imaging at set intervals is the backbone of nodule management for indeterminate findings.
Subsolid Nodules Are a Special Category
Not all nodules are solid white spots on a CT image. Some appear hazy, like frosted glass, and are called ground-glass nodules. Others have a ground-glass haze with a solid core, known as part-solid nodules. Together, these are called subsolid nodules, and they occupy an uncomfortable middle ground: they carry a higher risk of being malignant than purely solid nodules, but when they are malignant, the cancers they represent tend to grow very slowly.8PubMed Central. Subsolid pulmonary nodules: Controversy and perspective
Data from the National Lung Screening Trial illustrate the challenge. Among subsolid nodules initially classified as low-risk by standard criteria, the actual malignancy rate was around 3%, higher than the 1% the classification system predicted. For those classified as intermediate-risk, the malignancy rate reached 14%, well above the expected 2%.9PubMed Central. Cancer Risk in Subsolid Nodules in the National Lung Screening Trial These findings have pushed clinicians to take subsolid nodules more seriously, even small ones.
The slow growth of subsolid nodules means patience is often appropriate. A study following over 300 patients with persistent subsolid nodules found that pure ground-glass nodules took a median of nearly eight years to grow, while part-solid nodules grew faster, with a median time of about two years. The practical takeaway is that many subsolid nodules can be safely monitored over years, but they do need monitoring, because a meaningful fraction will eventually progress.10PubMed Central. Long-term follow-up of persistent pulmonary subsolid nodules: Natural course of pure, heterogeneous, and real part-solid ground-glass nodules
How Doctors Decide What to Do Next
The main framework guiding nodule management in the United States is the Fleischner Society guidelines, last updated in 2017. These recommendations set a minimum size threshold below which routine follow-up is unnecessary for most patients and provide a range of follow-up intervals rather than a single fixed timeline, giving doctors and patients flexibility based on individual risk factors.11PubMed Central. Guidelines for Management of Incidental Pulmonary Nodules Detected on CT Images: From the Fleischner Society 2017 For people at low risk with small nodules, the guidelines essentially say: leave it alone.
For lung cancer screening specifically, the Lung-RADS system categorizes nodules from 1 (negative) to 4 (suspicious). This system substantially reduced false-positive results compared with earlier screening criteria, cutting the positive rate from roughly 28% to about 11% in one clinical program.12Journal of the American College of Radiology. Performance of ACR Lung-RADS in a Clinical CT Lung Screening Program The tradeoff is a modest decrease in sensitivity, meaning a few cancers are initially classified as lower risk and caught at the next screening round rather than immediately.13PubMed Central. Performance of Lung-RADS in the National Lung Screening Trial: a retrospective assessment For most patients, that tradeoff is worthwhile because it prevents a cascade of unnecessary biopsies and anxiety from false alarms.
Risk-prediction models add another layer of refinement. The Brock model, one of the most widely validated, uses features like nodule size, type, location, and patient characteristics to estimate the probability that a given nodule is malignant. When tested against a large dataset, the model performed well overall but tended to overestimate cancer probability and needed recalibration. Of all the patient-level risk factors tested, smoking history measured in pack-years was the only one that significantly improved the model’s predictions.14Thorax. External validation and recalibration of the Brock model to predict probability of cancer in pulmonary nodules using NLST data
PET Scans and Biopsies
When a nodule is large enough or suspicious enough to need more information, PET/CT scanning is often the next step. PET/CT combines the anatomical detail of a CT scan with a metabolic tracer that highlights areas of high cellular activity, which cancers tend to have. In one study, PET/CT achieved an overall accuracy of 93% in classifying solitary nodules as benign or malignant, with a sensitivity of 97% and a specificity of 85%.15Journal of Nuclear Medicine. Accuracy of PET/CT in Characterization of Solitary Pulmonary Lesions
PET does have blind spots. It performs poorly on subsolid and nonsolid nodules, where sensitivity drops dramatically, and it is less reliable in regions where infectious lung diseases are common because active infections light up on PET the same way cancers do. In areas with endemic fungal infections, the specificity of PET drops from about 77% to around 61%.16PubMed Central. Accuracy of FDG-PET to diagnose lung cancer in areas with infectious lung disease: A meta-analysis A positive PET result in a patient who lives in the Ohio River Valley, for example, has to be interpreted with more caution than the same result in someone from a region without endemic fungal exposure.
If imaging still leaves things uncertain, a tissue sample is the definitive answer. There are two main biopsy approaches for lung nodules. CT-guided needle biopsy, where a needle is passed through the chest wall into the nodule under CT guidance, has a higher diagnostic yield, around 86% in one head-to-head comparison.17PubMed. Electromagnetic Navigational Bronchoscopy versus CT-guided Percutaneous Sampling of Peripheral Indeterminate Pulmonary Nodules: A Cohort Study Navigational bronchoscopy, where a flexible scope is threaded through the airways to reach the nodule from the inside, has a lower yield but tends to produce fewer complications like collapsed lungs. One cost-consequences analysis estimated that in a group of 100 patients, the bronchoscopy approach would result in roughly 13 fewer cases of pneumothorax and 6 fewer chest tubes compared with CT-guided biopsy.18PubMed Central. Navigational Bronchoscopy with Biopsy versus CT-guided Biopsy for the Diagnosis of a Solitary Pulmonary Nodule: A Cost-Consequences Analysis The choice between the two depends on where the nodule sits, its size, the patient’s lung function, and the expertise of the local medical team.
When Surgery Becomes the Answer
For nodules that remain suspicious after imaging and possibly biopsy, surgical removal is both a diagnostic and a therapeutic step. The most common approach is video-assisted thoracoscopic surgery (VATS) wedge resection, a minimally invasive procedure where the surgeon removes a small wedge of lung tissue containing the nodule through small incisions.19PubMed Central. Optimizing peripheral lung nodule resection: benefits of CO(2)-infused micro-port VATS over single-port VATS If the tissue comes back benign, the problem is solved. If it comes back as cancer, the surgeon already has a head start: early-stage lung cancers caught as small nodules have far better survival rates than cancers found at later stages.
Small or deep nodules can be tricky to find during surgery because the surgeon cannot feel them through the camera ports. To solve this, some centers mark the nodule before surgery using a tiny metallic coil placed under CT guidance. In one series, this technique allowed successful wedge resection in 97% of patients.20PubMed Central. CT-guided microcoil VATS resection of lung nodules: a single-centre experience and review of the literature The procedure keeps the amount of lung tissue removed to a minimum, which matters for preserving breathing capacity.
The Overdiagnosis Problem
One underappreciated risk of finding so many nodules is that some benign ones get treated as if they were malignant. A retrospective study found an overdiagnosis rate of 50% among pulmonary nodules that were surgically removed, meaning half of the resected nodules turned out to be benign on final pathology. Nodules that appeared non-solid on imaging, showed signs of pleural retraction, or were larger were more likely to be overdiagnosed.21PubMed Central. Factors associated with overdiagnosis of benign pulmonary nodules as malignancy: a retrospective cohort study That is a sobering number. For every patient whose cancer is caught early because of aggressive workup, there is potentially another patient who went through unnecessary surgery for something that was never going to hurt them.
This tension between catching real cancers and avoiding unnecessary procedures is the central challenge in pulmonary nodule management. It is why guidelines have progressively raised the size threshold at which follow-up imaging is recommended and why risk-prediction models are being refined. The goal is not to investigate every single nodule but to accurately sort the small number that matter from the overwhelming number that do not.
The Psychological Toll of a Nodule Finding
Even when a nodule is almost certainly benign, finding out you have one can be stressful. In a multicenter survey, about a quarter of patients reported clinically significant distress related to their incidental pulmonary nodule. The most common concerns were uncertainty about the cause (78% of respondents), the possibility of cancer (73%), and the potential need for surgery (64%).22PubMed Central. Patients’ Knowledge, Beliefs, and Distress Associated with Detection and Evaluation of Incidental Pulmonary Nodules for Cancer: Results from a Multicenter Survey
A broader scoping review of 19 studies found that the prevalence of distress among patients with pulmonary nodules ranged from 24% to 57%, with anxiety reported in roughly 10% to 42% and depression in 15% to 27%.23PubMed. Pulmonary nodules and the psychological harm they can cause: A scoping review These are not trivial numbers. Months of waiting for follow-up scans, each with its own burst of pre-appointment worry, can meaningfully affect quality of life.
Education helps. One quality improvement project gave patients a simple fact sheet about pulmonary nodules. Before reading it, about 60% of patients worried about their nodule at least once a month and about a fifth worried daily. After reviewing the fact sheet, over 83% reported improved anxiety.24PubMed Central. Effect of a pulmonary nodule fact sheet on patient anxiety and knowledge: a quality improvement initiative The core message that resonated was the one this article leads with: the overwhelming majority of lung nodules are not cancer. When people actually understand the numbers, the waiting becomes more bearable.
How risk information is presented matters too. A study testing different formats for communicating lung cancer screening risks found that combining numbers with icon arrays, those grids of figures where some are highlighted to represent a proportion, produced better knowledge scores than numbers alone or narrative descriptions.25PubMed Central. Shared Medical Decision Making in Lung Cancer Screening: Experienced versus Descriptive Risk Formats If your doctor tells you there is a 3% chance your nodule is cancer, that can sound terrifying in the abstract. Seeing three figures shaded out of a hundred is a different experience, and it tends to calibrate worry more accurately.
How Artificial Intelligence Is Changing Nodule Detection
AI systems are increasingly being used alongside radiologists to read CT scans, and the evidence suggests they are genuinely useful. Current AI tools achieve sensitivity above 95% for detecting nodules on CT, with fewer than one false-positive per scan on average.26PubMed Central. Artificial intelligence in automated detection of lung nodules: a narrative review They are especially good at catching nodules that are easy for humans to miss: small ones, ground-glass ones, and ones tucked into tricky locations near blood vessels or the edges of the lung.
A study evaluating AI assistance for radiologists found that the software significantly reduced false-positive calls and improved detection of error-prone nodules, the kinds that are small, centrally located, or have a ground-glass appearance.27PubMed Central. Deep Learning-based Artificial Intelligence Improves Accuracy of Error-prone Lung Nodules Junior radiologists in particular benefited from AI as a second reader, gaining both accuracy and confidence in their assessments. The technology is not replacing human readers but is functioning as a reliable safety net, catching things that might otherwise slip through on a busy day.
Fungal Infections and Geography
If you live in or have traveled through certain parts of North America, the odds that your lung nodule is a harmless leftover from a fungal infection go up substantially. Histoplasmosis, caused by a fungus found in soil enriched by bird and bat droppings, remains heavily concentrated in the Ohio and Mississippi River Valleys but has expanded well beyond its historical boundaries into the upper Midwest and Great Plains. Blastomycosis is concentrated around the Great Lakes and major eastern waterways. Coccidioidomycosis, commonly called valley fever, is endemic to the desert Southwest, particularly California’s San Joaquin Valley and southern Arizona.2CHEST Pulmonary. Endemic Mycoses for Pulmonary Clinicians: From Nodules to ARDS
All three of these infections can produce lung nodules that look worrisome on imaging. In endemic areas, they account for a large share of the benign nodules that trigger further workup and sometimes unnecessary biopsies. This geographic context is something your doctor should ask about: where you have lived and traveled can shift the interpretation of a nodule dramatically. A spiculated, PET-positive nodule in a lifelong Phoenix resident with outdoor occupational exposure warrants a different degree of suspicion than the same nodule in someone with a 40-pack-year smoking history and no fungal exposure history. Both need workup, but the prior probabilities are different, and that should affect how aggressively things proceed.
One emerging wrinkle is that the endemic maps for these fungi are expanding, likely due to climate change and land-use shifts. Cases of histoplasmosis and blastomycosis are now being diagnosed in states that were previously considered non-endemic. Clinicians in these newly affected areas may be less familiar with fungal nodules, increasing the chance of misinterpretation. If you are told a nodule needs a biopsy and you have lived in or traveled through any of these regions, it is worth mentioning that exposure history to your care team, even if they do not ask.
A plasma-protein-based blood test is also under development that may help sort indeterminate nodules without an invasive procedure. In a validation study, the test achieved a negative predictive value of 94%, meaning that when it classified a nodule as low risk, it was almost always right.28PubMed Central. Risk assessment for indeterminate pulmonary nodules using a novel, plasma-protein based biomarker assay Blood-based biomarkers like this are not yet standard practice, but they represent the direction the field is moving: fewer biopsies for benign nodules and more targeted workup for suspicious ones.